The calculus of national medical research policy - The United States versus Asia

New England Journal of Medicine

Volumn 367, Issue 8, 2012, Pages 687-690

  Sun, Gordon H ^a,b,d   Steinberg, Jeffrey D ^e   Jagsi, Reshma ^a,c  

^a Robert Wood Johnson Foundation Clinical Scholars Program   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^e AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ASIA; BUDGET; CHINA; ECONOMIC DEVELOPMENT; FUNDING; GOVERNMENT; HEALTH CARE QUALITY; HUMAN; INDIA; INVESTMENT; MEDICAL RESEARCH; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REIMBURSEMENT; SHORT SURVEY; SINGAPORE; SOUTH KOREA; TAIWAN; UNITED STATES;

EID: 84865287589     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1206643     Document Type: Article

References (5)

1. Murphy KM, Topel RH. The economic value of medical research. Chicago: University of Chicago Press, 1998.
2. Collins FS. Fiscal Year 2012 budget request. Bethesda, MD: National Institutes of Health, 2011 (http://www.nih.gov/about/director/budgetrequest/ fy2012budgetrequest.pdf).
3. Ehrlich E. Engine stalled: sequestration's impact on NIH and the biomedical research enterprise. United for Medical Research, 2012 (http://www.unitedformedicalresearch.com/wp-content/uploads/2012/03/ UMRSequestration-Impact-on-NIH-2012.pdf).
4. Thiers FA, Sinskey AJ, Berndt ER. Trends in the globalization of clinical trials. Nat Rev Drug Discov 2008;7:13-4.
5. Ding Y. In China, publish or perish is becoming the new reality. Science 2001;291:1477-9.